All In Biotech

Free tool

FAERS Monitor: Cycloset

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020866 or its brand name (Cycloset, Bromocriptine Mesylate). Reports on generic versions are filed under their own applications.

Reports

646

Serious

513

79% of reports

Hospitalization

234

Death reported

30

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea46
  • drug ineffective37
  • headache35
  • vomiting33
  • dizziness31
  • pyrexia29
  • fatigue28
  • drug exposure during pregnancy25
  • neuroleptic malignant syndrome24
  • tremor22
  • somnolence20
  • diarrhoea19
  • dyspnoea19
  • blood creatine phosphokinase increased18
  • hypotension18

Reports by year received

View as table
YearReports
200432
200530
200634
200733
200837
200915
201019
201178
201262
201316
201416
201530
201629
201730
201823
201921
20208
202116
202222
202327
202445
202514
20268

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,513 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
neuroleptic malignant syndromeSignal2466.044.61,470
drug exposure during pregnancySignal2524.016.3528
blood creatine phosphokinase increasedSignal1820.412.9313
tremorSignal224.32.953
somnolenceSignal203.22.129
hypotensionSignal182.91.921
pyrexiaSignal292.71.931
vomitingSignal332.31.623
dizzinessSignal312.01.415
nausea461.91.419
headache351.81.312
fatigue281.20.81
dyspnoea191.10.70
diarrhoea191.00.60
drug ineffective370.90.70

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.